Get started
Author

Francesco Sica

Observed names: F. Sica, Sica, Francesco
ORCID: 0000-0002-7255-952X
Observed ORCID: 0000-0002-7255-952X
OpenAlex ID: A5031040136
Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
2014 · Claudio Liguori, Andrea Romigi, et al. · JAMA Neurology · 363
Obesity worsens central inflammation and disability in multiple sclerosis
2019 · Mario Stampanoni Bassi, Ennio Iezzi, et al. · Multiple Sclerosis Journal · 132
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
2020 · Mario Stampanoni Bassi, Ennio Iezzi, et al. · Frontiers in Cellular Neuroscience · 86
PDF
Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria
2018 · on behalf of the Neuropathic Pain Special Interest Group of the Italian Neurological Society, Claudio Solaro, et al. · Journal of Neurology · 61
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis
2019 · Mario Stampanoni Bassi, Ennio Iezzi, et al. · Neurorehabilitation and neural repair · 59
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism?
2014 · Giuseppe Sancesario, Luigi Antonio Morrone, et al. · Neurochemistry International · 42
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
2019 · Giovanni Novi, Francesca Bovis, et al. · Multiple Sclerosis and Related Disorders · 36
Fingolimod Immune Effects Beyond Its Sequestration Ability
2019 · Francesco Sica, Diego Centonze, et al. · Neurology and Therapy · 33
PDF
Sundowning Syndrome: A Possible Marker of Frailty in Alzheimer’s Disease?
2013 · Davide Ferrazzoli, Francesco Sica, et al. · CNS & Neurological Disorders - Drug Targets · 17
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients
2019 · Mario Stampanoni Bassi, Fabio Buttari, et al. · Clinical Neurophysiology · 15
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients
2020 · Mario Stampanoni Bassi, Jelena Drulovic, et al. · Therapeutic Advances in Neurological Disorders · 9
Electroencephalography and Dementia: A Literature Review and Future Perspectives
2013 · Davide Ferrazzoli, Maria Albanese, et al. · CNS & Neurological Disorders - Drug Targets · 9
Fingolimod reduces the clinical expression of active demyelinating lesions in MS
2018 · Elisabetta Signoriello, Doriana Landi, et al. · Multiple Sclerosis and Related Disorders · 7
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS
2025 · Shalom Haggiag, Luca Prosperini, et al. · JAMA Network Open · 5
PDF
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty
2025 · Gina Ferrazzano, Roberta Fantozzi, et al. · Neurology and Therapy · 5
PDF
Neuromuscular Electrical Stimulation Does Not Influence Spinal Excitability in Multiple Sclerosis Patients
2024 · Martina Scalia, Riccardo Borzuola, et al. · Journal of Clinical Medicine · 4
PDF
Neuromuscular electrical stimulation reduces spinal excitability in Multiple Sclerosis patients with spasticity symptoms
2025 · Martina Scalia, Riccardo Borzuola, et al. · Multiple Sclerosis and Related Disorders · 3
ADA Genetic Variants Influence Central Inflammation and Clinical Characteristics in MS: Implications for Cladribine Treatment (P4.2-044)
2019 · Mario Stampanoni Bassi, Fabio Buttari, et al. · Neurology · 1
Clinical phenotype and treatment response in AQP4-IgG-positive NMOSD and MOGAD: insights from the Italian I-MS&RD registry
2026 · Carla Tortorella, Alessandro Cruciani, et al. · Journal of Neurology
Correlation between epileptiform activity and cerebrospinal fluid biomarkers in Alzheimer's disease
2013 · M. Albanese, D. Ferrazzoli, et al. · Journal of the Neurological Sciences
Levodopa induced alterations in cyclic nucleotide levels, a new aspect in the pathogenetic mechanism of Parkinson's disease
2011 · V. Castelli, V. D'Angelo, et al. · IRIS Research product catalog (Sapienza University of Rome)
Works count: 26
Citation count: 887
H-index: 10
I10-index: 10
Year
Topic
Type